Skip to main content

Payden & Rygel

SEC CIK
0000919219
Latest filing
Jul 31, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2025
Holdings of REGN by Payden & Rygel, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−16,100−100.0%Sold outHolders
Q1 202516,100$10.2M0.9%+16,100NewHolders